These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4017423)

  • 21. [Experience with sulindac in rheumatoid arthritis and osteoarthritis].
    Huskisson EC
    Reumatizam; 1980; 27(2):35-7. PubMed ID: 6996064
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat.
    Swanson BN; Mojaverian P; Boppana VK
    J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal metabolism of sulindac: functional implications.
    Miller MJ; Bednar MM; McGiff JC
    J Pharmacol Exp Ther; 1984 Nov; 231(2):449-56. PubMed ID: 6436473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials of Sulindac in rheumatoid and osteoarthritis.
    Huskisson EC
    Acta Rhumatol Belg; 1977; 1(3-4):257-61. PubMed ID: 388989
    [No Abstract]   [Full Text] [Related]  

  • 25. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa.
    Graham DY; Smith JL; Holmes GI; Davies RO
    Clin Pharmacol Ther; 1985 Jul; 38(1):65-70. PubMed ID: 3874038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
    Duggan DE; Hooke KF; Hwang SS
    Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sulindac and indomethacin on renal prostaglandin synthesis.
    Sedor JR; Williams SL; Chremos AN; Johnson CL; Dunn MJ
    Clin Pharmacol Ther; 1984 Jul; 36(1):85-91. PubMed ID: 6428794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of sulindac and its metabolites in human plasma and urine by high-performance liquid chromatography.
    Swanson BN; Boppana VK
    J Chromatogr; 1981 Sep; 225(1):123-30. PubMed ID: 7298740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro metabolism of sulindac and sulindac sulfide: enzymatic formation of sulfoxide and sulfone.
    Kitamura S; Tatsumi K
    Jpn J Pharmacol; 1982 Oct; 32(5):833-8. PubMed ID: 7176218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of sulindac with other cyclooxygenase inhibitors on prostaglandin excretion and renal function in normal and chronic bile duct-ligated dogs and swine.
    Zambraski EJ; Chremos AN; Dunn MJ
    J Pharmacol Exp Ther; 1984 Mar; 228(3):560-6. PubMed ID: 6423807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placental transfer of sulindac and its active sulfide metabolite in humans.
    Kramer WB; Saade G; Ou CN; Rognerud C; Dorman K; Mayes M; Moise KJ
    Am J Obstet Gynecol; 1995 Mar; 172(3):886-90. PubMed ID: 7892880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of sulindac and its metabolites on acute stress-induced gastric ulcers in rats.
    Glavin GB; Sitar DS
    Toxicol Appl Pharmacol; 1986 Apr; 83(2):386-9. PubMed ID: 3961821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane effects of antiinflammatory agents. 1. Interaction of sulindac and its metabolites with phospholipid membrane, a magnetic resonance study.
    Fan SS; Shen TY
    J Med Chem; 1981 Oct; 24(10):1197-202. PubMed ID: 6276543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oral dosing paradigms (gavage versus diet) on pharmacokinetics and pharmacodynamics.
    Kapetanovic IM; Krishnaraj R; Martin-Jimenez T; Yuan L; van Breemen RB; Lyubimov A
    Chem Biol Interact; 2006 Dec; 164(1-2):68-75. PubMed ID: 17027946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of sulindac with ibuprofen in the management of rheumatoid arthritis.
    Burry HC; Witherington L
    N Z Med J; 1979 Apr; 89(634):298-300. PubMed ID: 377154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulindac, reactive oxygen, and arthritis.
    Bodaness RS
    Med Hypotheses; 1979 Oct; 5(10):1129-30. PubMed ID: 522698
    [No Abstract]   [Full Text] [Related]  

  • 38. A controlled clinical study comparing sulindac with ibuprofen and aspirin in the treatment of musculo-skeletal diseases.
    Oyemade GA; Onadeko BO
    J Int Med Res; 1979; 7(6):556-9. PubMed ID: 160348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The disposition of sulindac.
    Duggan DE; Hare LE; Ditzler CA; Lei BW; Kwan KC
    Clin Pharmacol Ther; 1977 Mar; 21(3):326-35. PubMed ID: 300048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical methods for the determination of sulindac and metabolites in plasma, urine, bile, and gastric fluid by liquid chromatography using ultraviolet detection.
    Musson DG; Vincek WC; Constanzer ML; Detty TE
    J Pharm Sci; 1984 Sep; 73(9):1270-3. PubMed ID: 6491950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.